Kálium-Klorid B.Braun (Potassium Chloride)

Potassium chloride dissociates after infusion, releasing potassium ions that increase extracellular potassium concentration. This restores the normal electrochemical gradient across cell membranes, supporting cardiac conduction, nerve impulse transmission, and muscle contraction.

The dose of Kálium‑Klorid B.Braun is determined by the prescribing clinician based on the patient’s serum potassium level, renal function, and overall clinical condition. The prescriber sets the concentration, infusion rate, and total amount required for each individual case.

Safety data for potassium chloride in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Kálium‑Klorid B.Braun is an injectable formulation, allowing rapid correction of potassium deficits, whereas oral potassium salts (e.g., potassium chloride tablets) provide slower, more gradual supplementation. Intravenous delivery is preferred in acute settings or when oral intake is not feasible.

Store the product at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from light and moisture, and avoid freezing. Follow standard aseptic handling procedures when preparing the solution for infusion.

The solution is given by intravenous infusion. It is typically diluted in a compatible IV fluid and administered at a rate prescribed by the clinician, often using an infusion pump to control the delivery speed and avoid rapid shifts in serum potassium.

The most serious risks include severe hyperkalemia, which can cause life‑threatening cardiac arrhythmias, anaphylactic reactions, and tissue injury from extravasation. Continuous monitoring of serum potassium and cardiac rhythm is essential during administration.

Contraindications include patients with existing hyperkalemia, severe renal failure, untreated metabolic acidosis, or known hypersensitivity to potassium chloride. Clinicians should also avoid use in patients with conditions that predispose to rapid potassium shifts without close monitoring.